Dutch companies Batavia Bioservices and Xendo have announced a strategic business collaboration providing Batavia Bioservices with access to Xendo?s simulated moving bed purification technology.
Dutch companies Batavia Bioservices and Xendo have announced a strategic business collaboration providing Batavia Bioservices with access to Xendo’s simulated moving bed purification technology. All bioprocess activities of Xendo have been transferred and the company will also provide infrastructure, knowledge and experience in microbial process and product development.
Menzo Havenga, CEO of Batavia Bioservices, explains: "It is fully expected that our collaboration will result in more customers being offered a complete development services package.”
The companies have also announced that they will also establish joint marketing efforts whereby Xendo BV will provide engineering, regulatory and clinical support services and Batavia Bioservices will provide process development and analytical services.
André van de Sande, CEO of Xendo, adds, “I trust that by combining our forces both companies are better positioned to service our customers. This helps Xendo, both in the Netherlands and internationally, to further expand."
For more information on the companies, visit their websites at www.bataviabioservices.com and www.xendo.com
Inside the Laboratory: The Gionfriddo Group at the University at Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.